LEXX
Lexaria Bioscience CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$17.63M
P/E Ratio
—
EPS
$-0.47
Beta
0.48
52W High
$1.55
52W Low
$0.46
50-Day MA
$0.81
200-Day MA
$0.89
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lexaria Bioscience Corp
Lexaria Bioscience Corp. The company is headquartered in Kelowna, Canada.
Fundamentals
| Revenue (TTM) | 368,000 |
| Gross Profit (TTM) | 368,000 |
| EBITDA | $-9.13M |
| Operating Margin | -7260.00% |
| Return on Equity | -147.10% |
| Return on Assets | -76.00% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $0.27 |
| Price-to-Book | 2.70 |
| Price-to-Sales (TTM) | 47.91 |
| EV/Revenue | 34.45 |
| EV/EBITDA | -7.22 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -88.50% |
| Shares Outstanding | $24.79M |
| Float | $23.44M |
| % Insiders | 5.74% |
| % Institutions | 6.44% |
Historical Volatility
HV 10-Day
128.85%
HV 20-Day
128.06%
HV 30-Day
113.33%
HV 60-Day
98.95%
HV Rank
—
Volatility is currently expanding
Data last updated: 5/2/2026